Dr David Gershenson is widely recognised as the foremost expert in low-grade serous ovarian cancer. In this presentation delivered at our American research partner STAAR‘s LGSOC Patient Conference in February 2025, he shares the progress low-grade serous ovarian cancer has made, from it’s discovery as a unique cancer, to the first clinical trial, to future directions.
Visit STAAR Low-Grade Serous Ovarian Cancer Foundation’s video library to watch more presentations from their LGSOC conference.
Special thanks to conference video sponsor Not These Ovaries.
